Lento Bio was formed in 2022 in partnership with Ichor Life Sciences, with the goal to develop effective, safe, and durable treatments for chronic age-related disease by using small molecules to directly target molecular damage.
Company Details
- Employees
- 2
- Founded
- 2022
- Address
- 831 James St, Syracuse,new York 13203,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://lentobio.com
- Keywords
- in ophthalmic drug development.
- HQ
- Syracuse, New York
Lento Bio Questions
Lento Bio's website is http://lentobio.com
Lento Bio's LinkedIn profile is https://www.linkedin.com/company/lentobio
Lento Bio has
2 employees.
View email and phone details for 2
employees at Lento Bio.
Lento Bio's industry is
Biotechnology Research
Lento Bio's top competitors are
Axa Foundation Inc,
Cypris Therapeutics, Inc.,
Ichor Life Sciences, Inc.,
Stonehenge Logistics.,
Telora,
Ichor Biologics Pvt. Ltd.,
Lento Group,
Ichor Biologics,
Intra-Cellular Therapies,
Apheon Bioscience.
Lento Bio's categories are Biotechnology Research
Lento Bio's founding year is 2022
